These findings collectively suggest that c-MPL could be a potential therapeutic target for addressing the process of multilineage cell depletion (thrombocytopenia, erythropenia, and neutropenia) associated with AA [3,7]. The gene discussed is MPL; the disease is Thrombocytopenia.